Лечение рака шейки матки в Индии

Yes. International patients can share their pathology reports, imaging, blood tests and previous treatment records for an initial specialist review before travelling. The specialist can assess the available information and advise whether additional investigations or an in-person evaluation are required in India.

Patients should provide their available biopsy or pathology reports, pelvic imaging such as MRI or CT, PET-CT reports where applicable, blood-test results, previous treatment summaries and current medication details. Complete records help the oncology team understand the diagnosis and disease extent before preparing the initial treatment plan.

A hospital may recommend a pathology review or additional testing when existing reports are incomplete, outdated or require confirmation for treatment planning. Additional imaging, pathology assessment or other investigations may also be recommended depending on the patient's diagnosis and available records.

Treatment options depend mainly on the stage and individual clinical characteristics. They can include surgery, external-beam radiation therapy, brachytherapy, chemotherapy and selected systemic treatments such as immunotherapy. Some patients receive a combination of radiation and chemotherapy, while selected early-stage patients may be candidates for surgery.

Yes. Brachytherapy is an established form of internal radiation therapy used in appropriate cervical cancer treatment plans, often alongside external-beam radiation. Its use depends on the patient's stage, anatomy, treatment objective and overall clinical assessment. India has dedicated radiotherapy and brachytherapy services at tertiary cancer centres.

Yes. International patients can request a second medical opinion by providing their pathology, imaging, staging information and previous treatment records. A specialist review can help clarify the diagnosis and discuss medically appropriate treatment options before the patient decides on a treatment pathway.

The cost varies according to the cancer stage and treatment plan. Expenses may include diagnostic investigations, surgery where required, chemotherapy, external radiation therapy, brachytherapy, medicines, hospitalisation and follow-up. Because each treatment pathway is different, an individualised estimate should be prepared after specialist review rather than relying on a single fixed price.

Yes. International patients from these regions can seek cervical cancer care in India, subject to medical assessment and applicable travel requirements. Having the medical records reviewed before travelling can help Welltara and the treating hospital coordinate the appropriate specialist consultation, investigations and treatment schedule in advance.

The required stay depends on the treatment pathway. Surgery may involve a shorter treatment period, while a treatment plan involving radiation therapy, chemotherapy and brachytherapy may require multiple visits over a longer period. The treating oncology centre should provide an individualised timeline based on the patient's diagnosis and planned treatment.

Follow-up arrangements can often be coordinated with an appropriate oncology team in the patient's home country, depending on the treatment completed in India. Before returning home, patients should obtain their treatment summary, pathology and imaging records, medication details and recommended follow-up schedule. Welltara can assist with coordinating relevant medical documentation with the treating hospital where applicable.

Welltara can help international patients organise medical records for specialist review, identify suitable hospitals and gynecologic oncology specialists, coordinate consultations and appointments, and support treatment-related travel arrangements such as accommodation and local coordination. The treating doctors and hospital remain responsible for diagnosis and medical decisions, while Welltara supports the patient's healthcare coordination journey